HR 1298
107th Congress
House
Taxation
Business income tax
Clinical trials
Commerce
Drug industry
Health
Income tax
Orphan drugs
Pharmaceutical research
Research and development tax credit
Science, Technology, Communications
Orphan Drug Tax Credit Act of 2001
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 29, 2001
Referred to the House Committee on Ways and Means.
Mar 29, 2001
Sponsor introductory remarks on measure. (CR E488)
Mar 29, 2001
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Orphan Drug Tax Credit Act of 2001 - Amends the Internal Revenue Code to move up the date for which a taxpayer may claim the credit for the clinical testing of drugs for rare diseases or conditions (orphan drugs) from the date a drug is designated an orphan drug to the date the application for such designation is filed.
What's happening now
Referred to the House Committee on Ways and Means.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). H.R. 1298: Orphan Drug Tax Credit Act of 2001. 107th Congress. Open America. https://openamerica.io/bill/107-HR-1298/
"H.R. 1298: Orphan Drug Tax Credit Act of 2001." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-1298/.
H.R. 1298, 107th Cong. (2026), https://openamerica.io/bill/107-HR-1298/.
[H.R. 1298: Orphan Drug Tax Credit Act of 2001](https://openamerica.io/bill/107-HR-1298/)